Text Module


Share

Program Content

Activities

  • Prostate Cancer Personalized Therapy
    Expert Think Tank on Applying the Latest Data to Individualize Treatment in Prostate Cancer
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 16, 2023

    Expires: August 15, 2024

Faculty

cover img faculity

Tanya B. Dorff, MD

Professor of Medicine
Vice Chair for Clinical Affairs
Department of Medical Oncology
City of Hope National Medical Center
Duarte, California

cover img faculity

Rana R. McKay, MD

Associate Professor of Medical Oncology and Urology
Associate Director, Clinical Sciences
Co-Lead, Genitourinary Malignancies Program
Moores Cancer Center
University of California San Diego
La Jolla, California

cover img faculity

Alicia Morgans, MD, MPH

Associate ProfessorDana-Farber Cancer InstituteBoston, Massachusetts

cover img faculity

Michael Schweizer, MD

Associate Professor
Clinical Research Division
Department of Medical Oncology
University of Washington
Fred Hutchinson Cancer Research Center
Seattle, Washington

cover img faculity

David VanderWeele, MD, PhD

Associate Professor
Department of Hematology/Oncology
Northwestern University
Attending Physician
Department of Hematology/Oncology
Jesse Brown VA Medical Center
Chicago, Illinois

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Bayer HealthCare Pharmaceuticals Inc., Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC, Lilly, Merck Sharp & Dohme Corp., and Novartis.

AstraZeneca

Bayer HealthCare Pharmaceuticals Inc.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Lilly

Merck Sharp & Dohme Corp.

Novartis

Partners

ZERO Prostate Cancer

ProCE Banner